CHRD

protein-coding

chordin, the group of Chordin family

Gene summary

This gene encodes a secreted protein that dorsalizes early vertebrate embryonic tissues by binding to ventralizing TGF-beta-like bone morphogenetic proteins and sequestering them in latent complexes. The encoded protein may also have roles in organogenesis and during adulthood. It has been suggested that this gene could be a candidate gene for Cornelia de Lange syndrome. Reduced expression of this gene results in enhanced bone regeneration. Alternative splicing results in multiple transcript variants. Other alternative splice variants have been described but their full length sequence has not been determined. [provided by RefSeq, Jan 2015]

MANE transcript

NM_003741.4

Inheritance

AR

ClinVar variants

U:171B:16

Top phenotype

Anophthalmia-microphthalmia syndrome

gnomAD constraint

pLI —, LoF o/e 0.34

Max pathogenic AF

—

Genomic locus

chr3:184,380,054-184,390,736

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~10.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital heart diseaseLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0005453

Submitter: ClinGen

*CHRD* was first reported in relation to autosomal recessive congenital heart disease in 2016 (Priest et al. 2016; PMID: 27058611). Two missense variants that have been reported in one proband in one publication (PMID: 27058611) are included in this curation. The mechanism of pathogenicity is unknown. This gene-disease relationship is also supported by biochemical function evidence (PMID: 15254540). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date October 17th, 2023 (SOP Version 9).

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CHRD variants in ClinVar

3 Conditions Cataloged
not specifiedTotal: 161
not providedTotal: 12
Anophthalmia-microphthalmia syndromeTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_003741.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
3
clinvar
3
clinvar
10
missense
158
clinvar
9
clinvar
1
clinvar
168
nonsense
1
clinvar
1
start loss
0
frameshift
2
clinvar
2
splice donor/acceptor (+/-2bp)
6
clinvar
6
Total00171124187
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 40 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_003741.4RefSeqNP_003732.223MANE Select
ENST00000204604.6EnsemblENSP00000204604.123MANE Select
NM_001304472.2RefSeqNP_001291401.123Standard
NM_001304473.2RefSeqNP_001291402.114Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
chrdDanio rerio

Structure: primordial germ cell

Quality: mislocalised

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • TGF-beta signaling pathway - Homo sapiens (human)
  • Mesodermal Commitment Pathway
  • alk in cardiac myocytes
  • BMP receptor signaling

Biological Process

  • skeletal system development
  • osteoblast differentiation
  • gastrulation with mouth forming second
  • mesoderm formation
  • positive regulation of mesenchymal cell proliferation

Molecular Function

  • protein binding
  • heparin binding
  • cytokine binding
  • syndecan binding

Cellular Component

  • extracellular space

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000204604
Coding exons
23
Length
10664
Individuals with no LoFs
125705
Homozygous LoFs
0
Heterozygous LoFs
43
Defined
125748
p
0.000171
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.464625590.8260.00003355937
Missense (PolyPhen)206258.780.796042724
Synonymous-0.3332392331.030.00001342088
Loss of Function4.261749.30.3450.00000272511

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000320.00025rare
Latino/Admixed American0.000230.00023rare
Ashkenazi Jewish0.000800.00079rare
East Asian0.000160.00016rare
Finnish0.000310.00028rare
European (Non-Finnish)0.000120.00011rare
South Asian00.0absent
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Dorsalizing factor. Key developmental protein that dorsalizes early vertebrate embryonic tissues by binding to ventralizing TGF-beta family bone morphogenetic proteins (BMPs) and sequestering them in latent complexes (By similarity). {ECO:0000250}.;

Recessive Scores

pRec
0.358

Intolerance Scores

LoFtool
0.715
RVIS EVS
-0.68
RVIS percentile EVS
15.36

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.661

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.